NO955320L - Substituerte 4-fenyltiazolderivater, fremgangsmåte for fremstilling derav og farmasöytiske blandinger som inneholder dem - Google Patents

Substituerte 4-fenyltiazolderivater, fremgangsmåte for fremstilling derav og farmasöytiske blandinger som inneholder dem

Info

Publication number
NO955320L
NO955320L NO955320A NO955320A NO955320L NO 955320 L NO955320 L NO 955320L NO 955320 A NO955320 A NO 955320A NO 955320 A NO955320 A NO 955320A NO 955320 L NO955320 L NO 955320L
Authority
NO
Norway
Prior art keywords
substituted
preparation
pharmaceutical compositions
compositions containing
phenylthiazole derivatives
Prior art date
Application number
NO955320A
Other languages
English (en)
Other versions
NO306114B1 (no
NO955320D0 (no
Inventor
Alain Badorc
Marie-Francoise Bordes
Paul De Cointet
Jean-Marc Herbert
Jean-Pierre Maffrand
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO955320D0 publication Critical patent/NO955320D0/no
Publication of NO955320L publication Critical patent/NO955320L/no
Publication of NO306114B1 publication Critical patent/NO306114B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO955320A 1994-12-28 1995-12-27 Substituerte 4-fenyltiazolderivater og farmasöytiske blandinger som inneholder dem NO306114B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9415805A FR2728901B1 (fr) 1994-12-28 1994-12-28 Derives de phenyl-4-thiazoles substitues, procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (3)

Publication Number Publication Date
NO955320D0 NO955320D0 (no) 1995-12-27
NO955320L true NO955320L (no) 1996-07-01
NO306114B1 NO306114B1 (no) 1999-09-20

Family

ID=9470360

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955320A NO306114B1 (no) 1994-12-28 1995-12-27 Substituerte 4-fenyltiazolderivater og farmasöytiske blandinger som inneholder dem

Country Status (28)

Country Link
US (1) US5607952A (no)
EP (1) EP0719775B1 (no)
JP (1) JP3027110B2 (no)
KR (1) KR960022515A (no)
CN (1) CN1048726C (no)
AR (1) AR002017A1 (no)
AT (1) ATE194616T1 (no)
AU (1) AU703490B2 (no)
BR (1) BR1100524A (no)
CA (1) CA2166165A1 (no)
CZ (1) CZ346595A3 (no)
DE (1) DE69517936T2 (no)
DK (1) DK0719775T3 (no)
ES (1) ES2148458T3 (no)
FI (1) FI956278L (no)
FR (1) FR2728901B1 (no)
GR (1) GR3034582T3 (no)
HU (1) HUT75096A (no)
IL (1) IL116560A (no)
NO (1) NO306114B1 (no)
NZ (1) NZ280720A (no)
PL (1) PL312078A1 (no)
PT (1) PT719775E (no)
RU (1) RU2124515C1 (no)
SI (1) SI0719775T1 (no)
SK (1) SK281247B6 (no)
TW (1) TW418207B (no)
ZA (1) ZA9511029B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US6010911A (en) * 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
US6319937B1 (en) 1998-11-18 2001-11-20 Dupont Pharmaceuticals Company Isoxazoline fibrinogen receptor antagonists
CA2345210A1 (en) 1998-11-18 2000-05-25 Prabhakar Kondaji Judhav Novel isoxazoline fibrinogen receptor antagonists
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
TWI284639B (en) * 2000-01-24 2007-08-01 Shionogi & Co A compound having thrombopoietin receptor agonistic effect
EP1648232A4 (en) * 2003-07-17 2009-12-30 Smithkline Beecham Corp ARGATROBAN TREATMENT METHOD FOR PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA
RU2321586C2 (ru) * 2003-08-12 2008-04-10 Ф.Хоффманн-Ля Рош Аг Производные тиазола в качестве антагонистов npy
KR100776961B1 (ko) * 2003-08-12 2007-11-28 시오노기세이야쿠가부시키가이샤 트롬보포이에틴 수용체 아고니스트 작용을 가지는 화합물
AU2005245271A1 (en) * 2004-05-13 2005-12-01 Boehringer Ingelheim International Gmbh Use of dipyridamole for treatment of resistance to platelet inhibitors
WO2005116623A2 (en) 2004-05-17 2005-12-08 Medtronic, Inc. Point of care heparin determination system
US7423053B2 (en) * 2004-07-15 2008-09-09 Hoffmann-La Roche Inc. 4-Aminothiazole derivatives
AU2005272389B2 (en) * 2004-08-11 2011-08-04 Kyorin Pharmaceutical Co., Ltd. Novel cyclic aminobenzoic acid derivative
US20090325924A1 (en) * 2005-06-30 2009-12-31 Stuart Edward GPCR Agonists
RU2373929C1 (ru) * 2008-11-11 2009-11-27 Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО БГМУ РОСЗДРАВА) Корректор системы гемостаза, проявляющий ингибирующее действие на адгезивно-агрегационную функцию тромбоцитов для профилактики патологического тромбообразования

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB542363A (en) * 1940-07-03 1942-01-06 Joseph Arthur Musgrave Woodcoc Improvements in or relating to the manufacture of graphite electrodes
DK157135C (da) * 1982-04-07 1990-04-02 Pfizer Analogifremgangsmaade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DE3839758A1 (de) * 1988-10-24 1990-04-26 Bayer Ag Substituierte 2-aminothiazole
US5231091A (en) * 1988-12-19 1993-07-27 American Cyanamid Company Bis-arylphosphate ester antagonists of platelet activating factor
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.
TW221996B (no) * 1991-11-14 1994-04-01 Glaxo Group Ltd
US5405848A (en) * 1993-12-22 1995-04-11 Ortho Pharmaceutical Corporation Substituted thiazolylaminotetrahydropyridopyrimidines derivatives useful as platelet aggregation inhibitors

Also Published As

Publication number Publication date
BR1100524A (pt) 2000-03-14
FI956278A0 (fi) 1995-12-27
DE69517936D1 (de) 2000-08-17
EP0719775A1 (fr) 1996-07-03
IL116560A (en) 2001-03-19
NZ280720A (en) 1997-10-24
FR2728901A1 (fr) 1996-07-05
TW418207B (en) 2001-01-11
ES2148458T3 (es) 2000-10-16
HU9503801D0 (en) 1996-02-28
CN1048726C (zh) 2000-01-26
CA2166165A1 (en) 1996-06-29
PT719775E (pt) 2000-12-29
NO306114B1 (no) 1999-09-20
DE69517936T2 (de) 2001-04-19
EP0719775B1 (fr) 2000-07-12
HUT75096A (en) 1997-04-28
KR960022515A (ko) 1996-07-18
SK281247B6 (sk) 2001-01-18
SK163395A3 (en) 1996-09-04
ATE194616T1 (de) 2000-07-15
DK0719775T3 (da) 2000-10-23
ZA9511029B (en) 1997-06-30
JPH08231542A (ja) 1996-09-10
PL312078A1 (en) 1996-07-08
NO955320D0 (no) 1995-12-27
RU2124515C1 (ru) 1999-01-10
JP3027110B2 (ja) 2000-03-27
US5607952A (en) 1997-03-04
FR2728901B1 (fr) 1997-03-28
AU703490B2 (en) 1999-03-25
CZ346595A3 (en) 1996-08-14
SI0719775T1 (en) 2000-12-31
FI956278A7 (fi) 1996-06-29
FI956278L (fi) 1996-06-29
AR002017A1 (es) 1998-01-07
AU4070995A (en) 1996-07-04
GR3034582T3 (en) 2001-01-31
CN1133289A (zh) 1996-10-16
IL116560A0 (en) 1996-03-31

Similar Documents

Publication Publication Date Title
DK0477049T3 (da) 3-amido-pyrazolderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem
NO942835L (no) 1-benzensulfonyl-1,3-dihydro-2H-benzimidazol-2-on-derivater, fremstilling derav og farmasöytiske blandinger som inneholder dem
HUP0000721A3 (en) Gemcitabine derivatives, process for their preparation and pharmaceutical compositions containing them
NO20001409L (no) Karboksamidotiazolderivater, fremgangsmÕte for fremstilling derav og farmasøytiske blandinger
NO975987D0 (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
NO305075B1 (no) Glycinamid-derivater, farmas°ytiske medikamenter som inneholder dem og mellomprodukter for fremstilling av dem
NO976128L (no) Forbindelser og farmasöytiske blandinger som inneholder dem
NO955320D0 (no) Substituerte 4-fenyltiazolderivater, fremgangsmåte for fremstilling derav og farmasöytiske blandinger som inneholder dem
FI952550A7 (fi) Uudet N-pyridyylikarboksamidit ja johdannaiset, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
HUP9602635A3 (en) 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
FI943688L (fi) Uudet 11-bentsaldoksiimi-17beta-metoksi-27alfa-metoksi-metyyli-estradieenijohdannaiset, menetelmät niiden valmistamiseksi ja näitä sisältävät lääkeaineet
NO950537D0 (no) Polysubstituerte 3-acylamino-5-fenyl-1,4-benzodiazepin-2-on-derivater, fremgangsmåter for fremstilling derav og farmasöytiske blandinger inneholdende dem
GB9617893D0 (en) New pharmaceutical derivatives, process for obtaining them and pharmaceutical compositions containing them
IL141956A0 (en) Benzothiazolone derivatives, process for their preparation and pharmaceutical compositions containing them
DK1117642T3 (da) Substituerede 1,3-diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)-propanolderivater, fremgangsmåder til fremstilling deraf, farmaceutiske præparater indeholdende dem og anvendelse deraf
NO960272L (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
NO20003290L (no) N-fenylamid- og N-pyridylamidderivater, fremgangsmÕte for fremstilling av dem, og farmasøytiske preparater som inneholder dem
NO20014803L (no) Pyrido-tieno-diazepiner, fremgangsmåte for fremstilling derav og farmasöytiske blandinger inneholdende dem
HUP0001183A3 (en) Pyrrolothiazine and pyrrolothiazepine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0003104A3 (en) Amino-spiropiperidin-quinazoline derivatives, their use, process for their preparation and pharmaceutical compositions containing them
DK0794184T3 (da) 6-Methoxy-1H-benzotriazol-5-carboxamidderivater, fremgangsmåde til fremstilling deraf og lægemidler indeholdende dem
FI944751A7 (fi) Heteroaryylipiperidiinejä, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
DK0776328T3 (da) 8-fluoranthracycliner, fremgangsmåder til fremstilling deraf og farmaceutiske præparater indeholdende dem
HUP0001432A3 (en) Pyrroloazepine derivatives, process for their preparation and pharmaceutical compositions containing them
DK0721456T3 (da) Anthracyclindisaccharider, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende dem

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JUNE 2002